PMS, Vigilance and Risk Management
Post-Market Surveillance (PMS) is more than complaint handling – it’s a strategic tool for patient safety, regulatory compliance, and continuous improvement. Under the EU MDR, a structured, proactive approach with strong links to risk management and authority dialogue is essential.
As Marie Mathiasson, Senior Quality and Regulatory Consultant at Aurevia explains, “An active and effective PMS system is not just a regulatory requirement; it’s essential to protect both patients and your company’s future.”
Read more about PMS, including 5 common pitfalls and how to avoid them.
Do you need support with PMS? At Aurevia, we can support you with PMS strategy, documentation, training, and regulatory guidance – so you can focus on what matters most: safety.
BREAKING